Free Trial

Exchange Traded Concepts LLC Takes $794,000 Position in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Exchange Traded Concepts LLC bought a new stake in Maximus, Inc. (NYSE:MMS - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 11,642 shares of the health services provider's stock, valued at approximately $794,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank purchased a new stake in shares of Maximus during the 4th quarter worth $71,443,000. SG Capital Management LLC acquired a new stake in shares of Maximus in the fourth quarter valued at about $30,285,000. Federated Hermes Inc. boosted its holdings in Maximus by 74.8% during the fourth quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock worth $65,912,000 after buying an additional 377,705 shares in the last quarter. Reinhart Partners LLC. grew its position in Maximus by 65.4% during the first quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider's stock worth $62,156,000 after buying an additional 360,365 shares during the period. Finally, Squarepoint Ops LLC acquired a new position in Maximus during the fourth quarter worth about $22,661,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Price Performance

Maximus stock traded up $0.95 during trading hours on Tuesday, hitting $69.52. The stock had a trading volume of 332,644 shares, compared to its average volume of 570,454. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.84 and a quick ratio of 1.84. The stock's fifty day moving average is $70.58 and its two-hundred day moving average is $70.93. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The stock has a market capitalization of $3.92 billion, a price-to-earnings ratio of 13.82 and a beta of 0.62.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The company had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.29 billion. During the same period in the previous year, the firm posted $1.57 earnings per share. The business's revenue for the quarter was up 1.0% compared to the same quarter last year. As a group, analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date was Thursday, May 15th. Maximus's payout ratio is 23.86%.

Insider Buying and Selling

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the company's stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the sale, the director now directly owns 14,205 shares in the company, valued at $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.

Read Our Latest Analysis on Maximus

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines